supported by the Shanghai Excellent Academic Leader(Grant No.21XD1423200)。
In the past year,several advancements have been achieved in the treatment of advanced non-small cell lung cancer(NSCLC),particularly in the areas of immunotherapy and targeted therapy.These achievements have provided ...
supported by the China Postdoctoral Science Foundation(Grant No.2023T160788);the Beijing Science and Technology Plan(Grant No.Z181100001718215).
The Chinese Society of Clinical Oncology Breast Cancer(CSCO BC)guidelines have been widely implemented in China since the first release in 2017.The Guideline Working Committee has also published multiple versions in E...
过去一年,晚期非小细胞肺癌(non-small cell lung cancer,NSCLC)多个临床研究报道更新了研究结果,晚期NSCLC治疗迎来了更多治疗选择、更优疗效及安全性。基于2023年3月—2024年2月的证据,中国临床肿瘤学会(Chinese Society of Clinical ...